← All trials
NCT00973908
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 1, 2010
- Primary completion
- Apr 1, 2012
- Completion date
- Dec 1, 2012
- First posted
- —
- Last posted
- —
- Enrollment
- 231
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- National Health Service, United KingdomLead sponsor
- Wirghtington Wigan and Leigh NHS TrustOverall official - principal investigator
- University of BristolCollaborator
- University of HullCollaborator
- FerringCollaborator
- Wrightington, Wigan and Leigh NHS Foundation TrustCollaborator
- South London and Maudsley NHS Foundation TrustCollaborator
- National Health Service, United KingdomReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.